$5.99
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 641 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Country

US

CEO

Dr. Daniel Virnich

IPO date

2020

Employees

641

ISIN

US68236X1000

Key stats

Open

$5.99

Volume

1.99M

Market cap

$564.90M

Prev. close

$5.85

Impl / hst vl

-

Open interest

$0.00

$5.99

Day’s Range

$5.99

$2.32

52W Range

$5.96

Valuation

16
Valuation score
Strongly Overvalued
P/E
-
P/S
1.03
P/B
-
Current ratio
1.47
Debt / Equity
-
ROE
-
Gross margin
15.81%
Income growth
-67.42%
FCF growth
-249.88

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$7.91
The top 5 analysts forecasts that 12-month price may increase by 31.97%, with a low of $7.07 and a high of $8.40
$7.07
Low
$7.91
Avg
$8.40
High
Current price

Earnings

Q1 ‘26 revenue
$147.44M
Q1 ‘26 net income
-$2.09M
Revenue
Net income
Previous EPS
-$0.02
Estimate EPS
-$0.07
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply